1
/
8
About Linvoseltamab
Dr Charlotte Pawlyn on managing infections
EHA 2025 | Shared Decision-Making (SDM)
EHA 2025 | IRAKLIA study
EHA 2025 | GMMG CONCEPT trial
EHA 2025 | GIMEMA CLARITY study
EHA 2025 | CARTITUDE-1
EHA 2025 | PREDATOR MRD clinical trial
EHA 2025 | RedirecTT 1 clinical trial
EHA 2025 | JNJ-5322, a novel, next generation-trispecific antibody
EHA 2025 | High risk myeloma
Masterclass 2025 | Patient Evidence
Masterclass 2025 | Early diagnosis challenges
Masterclass 2025 | Care for carers
MPE Masterclass 2025 | Sequencing of myeloma treatment
1
/
8